See inside every stock. Pro
S&P 5007,624▼ 0.52%Nasdaq25,955▼ 0.21%Dow Jones52,215▼ 1.23%Nasdaq 10028,958▼ 0.00%VIX19.45▲ 2.21%US Dollar101.75▲ 0.14%Gold spot4,012▼ 0.30%WTI103.27▲ 3.82%
← NVDA page
XStocksXray
Market X-Ray report · 23 October 2026

NVIDIA Corporation (NVDA)

SIX Swiss Exchange · Switzerland · prices in CHF · close of 23 Oct 2026

Key indicators

Last closeCHF 175.98
52-week range134.98 – 201.30
Return, 1 month / 3 months−5.7% / +4.4%
Return, 1 year / 3 years– / −100.0%
TrendAbove 200-day, below 50-day
RSI (14)38
Volatility (1 year)38.6%
Worst drawdown (1 year)-23.5%
Average daily value traded0.02M CHF
Dividend yield–

Market X-Ray price-based

50/ 100 · Medium confidence · ahead of 44% of stocks on this exchange
Trend68
Momentum64
Stability (higher is calmer)42
Liquidity10
Income–

Five-year price chart navy: price · brown: 200-day average

-59,796.49219,521498,839778,1571,057,4752021-102022-102023-102024-112026-10

About the company

NVIDIA Corporation designs and supplies graphics processing units and related hardware and software. Its chips power gaming graphics cards, professional workstations and data centre systems used for artificial intelligence and scientific computing. The company also provides software platforms and development tools for developers and enterprises. NVIDIA is based in Santa Clara, California, and its products are used by gamers, researchers, designers and technology companies around the world.

The shares are listed on the SIX Swiss Exchange in Switzerland under the code NVDA, and the price on this page is in Swiss francs (CHF). Dividend data for this stock is not available yet. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

NVIDIA Corporation (NVDA) trades on the SIX Swiss Exchange in Switzerland. It last closed at CHF 175.98 on 23 October 2026.

Its price-based Market X-Ray is 50 out of 100 (a weak price profile), ranking 127 of 226 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
NVIDIA Corporation (NVDA)

The five lenses in numbers each metric is ranked against the other stocks on SIX Swiss Exchange

Lens and metricValueScoreReading
Trend68 · FairMixed trend against its averages.
Above 200-day average8.0%
From 52-week high-12.6%
Momentum64 · FairTypical recent returns for this exchange.
3-month return4.4%
6-month return11.9%
12-month return, skipping the last month–
Stability (higher is calmer)42 · WeakVolatile, with deep drawdowns.
Volatility, 1 year (lower is calmer)38.6%
Worst drawdown, 1 year (smaller is calmer)-23.5%
Liquidity10 · WeakThinly traded: prices can jump and exits can be hard.
Average daily value traded0.02M CHF
Zero-volume days30.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

No lens stands out as a clear strength against its exchange.

Weak spots

  • Stability (higher is calmer): Volatile, with deep drawdowns.
  • Liquidity: Thinly traded: prices can jump and exits can be hard.

Returns

1 week−1.6%
1 month−5.7%
3 months+4.4%
6 months+11.9%
1 year–
3 years−100.0%
5 years+22.5%

Signals

50-day / 200-day average183.34 / 162.96
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)2.96

Technical summary

DailyBearish5 bullish · 1 neutral · 10 bearish
WeeklyBearish3 bullish · 0 neutral · 9 bearish
MonthlyBearish2 bullish · 0 neutral · 6 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on SIX Swiss Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 24 Oct 2026